Community Practice

Ned Milenkovich has been reappointed to the Illinois State Board of Pharmacy for an additional five-year term

As drug reimbursement policies change, one question keeps popping up. What will replace average wholesale price?

NABP has launched an initiative to transfer prescription monitoring program information across state lines

The time has come for pharmacists to work on reforming the maximum allowable costs put forth by the pharmacy benefit managers

A survey of new Rx, new generic, and new OTC products

A round-up of OTC products to help manage skin problems

Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution

A recent study indicated that the cost of diabetes treatment could be reduced if physicians prescribed more generics

Afatinib used in lung cancer treatment helped patients live longer, according to the results of a new phase 3 clinical trial.

Men with advanced prostate cancer treated with enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life, according to new data from the phase 3 AFFIRM study.

Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation.

U.S. Marshals recently seized misbranded Global Biotechnologies dietary supplements at the request of the FDA, and per a warrant issued by the U.S. District Court for the District of Maine, according to an FDA statement.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may prevent the development of skin cancer, according to a new study, published online first in the journal Cancer on May 29.

With the help of the National Community Pharmacists Association, community pharmacists are taking on the issue of medication nonadherence, which costs the nation about $300 billion each year, the organization announced in a recent statement.

The industry should collaborate to develop a U.S. Biopharmacopeia Registry of Biopharmaceutical Products to help resolve biosimilar and broader biopharmaceutical nomenclature issues, according to a leading author and publisher.

The Centers for Medicare & Medicaid Services is partnering with providers, caregivers, and patients to ensure appropriate use of antipsychotic medications for nursing home patients, the government announced last week.

The Obama administration?s plan to close the racial and ethnic gap on childhood asthma has drawn strong support from the Merck Childhood Asthma Network.

Intensive control of blood-sugar levels among patients with type 2 diabetes mellitus may reduce the risk of microalbuminuria and macroalbuminuria, signs of kidney damage, but evidence is lacking regarding the effect over renal end points, according to the results of a study published May 28 in Archives of Internal Medicine.

Patients taking statins for the first time demonstrated better medication adherence if they participated in face-to-face counseling sessions with a community pharmacist than patients who did not, according to a new study by Walgreens.

Walgreens, the nation's largest drugstore chain, and OptumRx, one of the largest pharmacy benefit managers in the United States, today announced they will extend a multi-year agreement that provides access to OptumRx's members at Walgreens' 7,800 locations.

The American Pharmacists Association was forced to take its website offline this week after the site was hacked into and defaced.

The most destructive thing an employer can do to an employee is to assign tasks that are impossible to accomplish. Retail chain pharmacists experience this daily.

Three major pharmacy associations have sent recommendations to FDA for maximizing the health benefit and costs savings of generic biologic products.

The use of benzocaine gels and liquids to sooth teething and mouth and gum pain can lead to a rare but serious--and sometimes fatal--condition called methemoglobinemia, according to an FDA Consumer Update.

FDA has warned consumers and healthcare professionals that counterfeit versions of Teva Pharmaceutical Industries' Adderall 30-mg tablets are being sold on the Internet.